MedPath

Use of ADHEAR, a Non-Implantable Bone Conduction Hearing System, in Children With Single Sided Deafness and/or Conductive Hearing Loss

Not Applicable
Conditions
Conductive Hearing Loss
Single Sided Deafness
Interventions
Device: ADHEAR Audio Processor
Registration Number
NCT03327194
Lead Sponsor
Queen Fabiola Children's University Hospital
Brief Summary

A hearing loss affects the quality of life and the natural development of children.

The new generation of hearing devices provides a huge number of options to them. These new hearing aids are often aesthetically acceptable, less invasive and user-friendly.

The ADHEAR Non-Implantable Bone Conduction Hearing System is connected directly to the skin with a special adhesive adapter. The device transmits the sound to the mastoid by vibrating on the skull and stimulates the inner ear without any previous surgery.

The objective of this study is to evaluate of the audiological benefit and subjective satisfaction of ADHEAR Audio Processor with Adhesive attachment in a group of children suffering from conductive hearing loss and/or single sided deafness.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Unilateral and/or bilateral CHL (e. g. BC-thresholds <25dB HL)
  • Ability to perform all tests required for the study
  • Signed, and dated informed consent by parents and children where applicable
Exclusion Criteria
  • intolerant of the materials
  • patient with a skin or scalp condition that may preclude the attachment of the adhesive plaster
  • fluctuation of hearing loss over a two year period of 15dB in either direction
  • retrocochlear, or central auditory disorders
  • any physical, psychological, or emotional disorder that would interfere with the ability to perform on test and rehabilitation procedures

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ADHEAR Audio processorADHEAR Audio Processor-
Primary Outcome Measures
NameTimeMethod
Maximal decibels gain measured by Audiological basic testsWeek 3
Maximal decibels gain measured by speech reception threshold in quietWeek 3
Secondary Outcome Measures
NameTimeMethod
Change from baseline in Quality of Life measured by the SSQ12 questionnairemonth 12
Comparison of maximal decibels gain measured by Audiological basic tests between ADHEAR Audio Processor and Cochlear bone anchored hearing aid.Day 0
Comparison of maximal decibels gain measured by speech reception threshold in quiet between ADHEAR Audio Processor and Cochlear bone anchored hearing aidDay 0
Change from baseline in patient and parents satisfaction measured by the ADHEAR Questionnairemonth 12
Incidence of device-emergent adverse event.Up to 1 year after start of study device utilization

Number of participants with device-related adverse events as assessed by CTCAE v4.0

Number of subjects who discontinue study device utilization due to any AE or dissatisfactionYear 1
Average time of daily use of ADHEAR Systemweek 3

Adherence reported by patient on a diary card.

Trial Locations

Locations (1)

Hôpital Universitaire Des Enfants Reine Fabiola

🇧🇪

Brussel, Belgium

© Copyright 2025. All Rights Reserved by MedPath